Schedule Friday, April 30, 2021 Noon – 1:00 p.m. ET Supported by Axsome Therapeutics Inc. [Product Theater 1] New Pathways in Depression: Potential to Improve Clinical Outcomes Roger S. McIntyre MD, FRCP Professor of...
Read MoreAPA is pleased to announce that Anthony Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases will deliver the 2021 William C. Menninger Memorial Convocation Lecture on May 2. At NIAID, Fauci...
Read MoreProf. Tony Traboulsee talks to Physician’s Weekly about his study of tolebrutinib Presented at the American Academy of Neurology (AAN) 2021 Annual Meeting, Anthony Traboulsee, MD, professor and research chair of the MS Society...
Read MoreAlthough the CheckMate-9ER trial, comparing cabozantinib plus nivolumab to sunitinib in frontline metastatic renal cell carcinoma (mRCC), had recently demonstrated improved progression-free survival (PFS) and overall survival...
Read MoreManagement of patients with multiple sclerosis (MS) in the era of disease modifying therapies (DMT) relies heavily on magnetic resonance imaging (MRI) and the support of dedicated multidisciplinary teams (MDTs). While decisions...
Read More
Are you caught up on advancements in treating allergic asthma? Test your knowledge on our...
Read More
Are you caught up on advancements in treating chronic idiopathic uriticaria (CIU)? Test your...
Read MoreDue to the COVID-19 pandemic, the 2021 American Academy of Neurology Annual Meeting, the world’s premier neurology meeting, will be held in a fully virtual format from April 17-22. It will include: Over 90 expert-led CME...
Read MoreCognitive impairment is a common and disabling feature of multiple sclerosis (MS), but a precise characterization of cognitive phenotypes in MS patients is still lacking. This study identified five cognitive phenotypes:...
Read MoreThe study team compared disability accrual in primary and secondary progressive multiple sclerosis (PPMS, SPMS) in the international MSBase cohort, using multivariable survival models, and applying objective diagnostic criteria...
Read MorePatients with MS may have difficulty performing double task (DT) while walking or causing interference. More research is needed in order to define the role of disability degree in the severity of the interference produced in the...
Read MoreManagement of patients with multiple sclerosis (MS) in the era of disease modifying therapies (DMT) relies heavily on magnetic resonance imaging (MRI). As physicians, decisions are influenced by the reporting prowess of...
Read MoreFEATURE: Laser Therapy Successful Against COVID-19 Pneumonia [Minute 2:15] [spreaker type=player resource=”episode_id=44175625″ theme=”light” autoplay=”false” playlist=”false”...
Read MoreEpisode Segments: FEATURE: Eggshell Skull and Pre-Existing Conditions [Minute 21:30] How the law regards liability when dealing with people who have a physical impairment has been in the news recently…if Derek Chauvin’s...
Read More
Chronic spontaneous urticaria (CSU) can be a debilitating condition that can significantly affect...
Read MoreA s a palliative care doctor in NYC during the beginning of the pandemic, my typical greeting response of “I’m fine” was speedily replaced with “I’m hanging in there.” It seemed slightly less false (because who’s really “fine”...
Read More
As the average age of people with multiple sclerosis (MS) increases, it becomes even more critical...
Read More
As the average age of people with multiple sclerosis (MS) increases, it becomes even more critical...
Read More
